General procedure for alkyl radical addition to glyoxylic
hydrazone 5
1486 cm−1. 1H NMR (CDCl3) d 7.45–7.21 (10H, m), 7.11
(1H, s), 4.01 (1H, dd, J = 8, 5.5 Hz), 3.41, 3.37 (each 1H, d,
J = 13.5 Hz), 2.15–2.08 (2H, m), 1.91–1.86 (3H, m), 1.45–1.34
(2H, m), 1.14, 0.95 (each 3H, s). 13C NMR (CDCl3) d 162.1,
129.9, 124.6, 65.4, 53.1, 48.6, 47.7, 44.8, 38.5, 32.9, 26.5, 21.0,
19.9. HRMS calcd for C24H27N3O3S (M+) 437.1772, found:
437.1773. Anal. calcd for C24H27N3O3S: C, 65.88; H, 6.22; N,
9.60; S, 7.33%. Found: C, 65.62; H, 6.19; N, 9.59; S, 7.49%.
To a micro tube containing 5 (50 mg, 0.2 mmol), RI (2.0 mmol),
zinc (92 mg, 1.4 mmol) and MeOH (0.2 mL) was added dropwise
aqueous sat. NH4Cl (0.4 mL) at 20 ◦C over 5 min. After being
stirred at the same temperature for 1 h, the reaction mixture
was diluted with 36% potassium sodium (+)-tartrate and then
extracted with CH2Cl2. The organic phase was washed, dried
over MgSO4 and concentrated at a reduced pressure. Purification
of the residue by preparative TLC (hexane–AcOEt, 5 : 1)
afforded 6a–e in the yields shown in Table 3.
General procedure for alkyl radical addition to chiral hydrazone 7
To a micro tube containing 7 (50 mg, 0.11 mmol), RI
(0.55 mmol), zinc (50.3 mg, 0.77 mmol) and CH2Cl2 (0.1 mL)
was added dropwise aqueous sat. NH4Cl (0.4 mL) at 20 ◦C over
5 min. After being stirred at the same temperature for 22 h,
the reaction mixture was diluted with 36% potassium sodium
(+)-tartrate and then extracted with CH2Cl2. The organic
phase was washed, dried over MgSO4 and concentrated at a
reduced pressure. Purification of the residue by preparative TLC
(hexane–AcOEt, 3 : 1) afforded 8a–c in the yields shown in
Table 4.
2-(2,2-Diphenylhydrazino)-3-methylbutanoic acid methyl ester
(6a). Colorless crystals. Mp 43–43.5 ◦C (hexane). IR (CHCl3)
1
3012, 1731, 1589, 1489 cm−1. H NMR (CDCl3) d 7.29–6.98
(10H, m), 4.40 (1H, br s), 3.45 (3H, s), 3.41 (1H, d, J = 6.3 Hz),
2.03–1.96 (1H, m), 1.07 (3H, d, J = 6.6 Hz), 0.97 (3H, d, J =
6.6 Hz). 13C NMR (CDCl3) d 173.8, 148.0, 129.0, 122.7, 120.9,
67.7, 51.2, 30.5, 19.2, 18.8. HRMS calcd for C18H22N2O2 (M+)
298.1680, found 298.1696. Anal. calcd for C18H22N2O2: C, 72.46;
H, 7.43; N, 9.39%. Found: C, 72.70; H, 7.44; N, 9.28%.
(3aR,6S,7aS)-Hexahydro-8,8-dimethyl-1-[(2R)-1-oxo-2-(2,2-
diphenylhydrazino)-3-(methyl)butyl]-3H-3a,6-methano-2,1-benz-
isothiazole 2,2-dioxide [(R)-8a]. Colorless crystals. Mp 145.5–
2-(2,2-Diphenylhydrazino)-3-methylpentanoic acid methyl es-
ter (6b). A 1 : 1 mixture of diastereomers with regard the sec-
butyl group. A colorless oil. IR (CHCl3) 3029, 3010, 2965, 1730,
◦
146.5 C (AcOEt–hexane). [a]2D3 +20.1 (c 1.00, CHCl3). IR
1
1589 cm−1. H NMR (CDCl3) d 7.29–6.98 (10H, m), 4.41 (1H,
(CHCl3) 3010, 2966, 1691, 1589, 1492 cm−1. 1H NMR (CDCl3)
d 7.28–7.15 (10H, m), 4.59 (1H, br s), 4.17 (1H, br s), 3.64
(1H, dd, J = 7.5, 5 Hz), 3.42, 3.38 (each 1H, d, J = 13.5 Hz),
2.18–2.14 (1H, m), 1.97–1.82 (5H, m), 1.39–1.28 (2H, m), 1.16,
0.90 (each 3H, d, J = 7 Hz), 1.07, 0.93 (each 3H, s). 13C NMR
(CDCl3) d 173.6, 149.1, 129.0, 122.8, 121.5, 67.8, 65.0, 52.9,
48.5, 47.8, 44.4, 38.4, 32.8, 32.1, 26.4, 20.7, 20.6, 19.9, 16.3.
HRMS calcd for C27H35N3O3S (M+) 481.2397, found 481.2402.
Anal. calcd for C27H35N3O3S: C, 67.33; H, 7.32; N, 8.72; S,
6.66%. Found: C, 67.30; H, 7.40; N, 8.62; S, 6.88%.
br s), 3.53–3.50 (1H, br m), 3.47 (3H, s), 1.84–1.72 (1H, m),
1.66–1.52 (1H, m), 1.38–1.16 (1H, m), 1.04–0.87 (6H, m). 13C
NMR (CDCl3) d 174.1, 169.9, 148.2, 148.1, 129.0, 122.7, 121.0,
66.1, 66.0, 51.3, 51.2, 37.4, 37.0, 26.0, 25.9, 15.5, 15.3, 11.7, 11.4.
HRMS calcd for C19H24N2O2 (M+) 312.1836, found 312.1847.
a-(2,2-Diphenylhydrazino)cyclopentaneacetic acid methyl ester
◦
(6c). Colorless crystals. Mp 52.5–53 C (AcOEt–hexane). IR
(CHCl3) 2953, 1732, 1589, 1497 cm−1. 1H NMR (CDCl3) d 7.29–
7.00 (10H, m), 4.28 (1H, br s), 3.42 (3H, s), 3.42 (1H, br m),
2.13–2.02 (1H, m), 1.98–1.88 (1H, m), 1.66–1.28 (7H, m). 13C
NMR (CDCl3) d 174.3, 148.0, 129.0, 122.7, 120.9, 66.9, 51.3,
41.6, 30.0, 29.0, 25.1, 24.9. HRMS calcd for C20H24N2O2 (M+)
324.1836, found 324.1836. Anal. calcd for C20H24N2O2: C, 74.04;
H, 7.46; N, 8.64%. Found: C, 74.05; H, 7.45; N, 8.62%.
(3aR,6S,7aS)-Hexahydro-8,8-dimethyl-1-[(2S)-1-oxo-2-(2,2-
diphenylhydrazino)-3-(methyl)butyl]-3H-3a,6-methano-2,1-benz-
isothiazole 2,2-dioxide [(S)-8a]. A yellow solid. [a]2D3 +34.5 (c
1.15, CHCl3). IR (CHCl3) 3018, 2966, 1685, 1589, 1493 cm−1.
1H NMR (CDCl3) d 7.27–7.12 (10H, m), 4.57 (1H, br s), 4.05
(1H, d, J = 4.5 Hz), 3.75 (1H, dd, J = 7.4, 4.2 Hz), 3.41, 3.34
(each 1H, d, J = 13.8 Hz), 2.20–2.09 (1H, m), 1.92–1.70 (5H,
m), 1.36–1.26 (2H, m), 1.13, 1.00 (each 3H, d, J = 6.9 Hz),
0.88, 0.85 (each 3H, s). 13C NMR (CDCl3) d 173.8, 148.7, 129.0,
122.7, 121.1, 66.9, 65.6, 53.0, 48.2, 47.6, 44.5, 38.5, 33.0, 30.1,
26.3, 21.0, 19.8, 16.9. HRMS calcd for C27H35N3O3S (M+)
481.2397, found 481.2404.
a-(2,2-Diphenylhydrazino)cyclohexaneacetic acid methyl ester
(6d). A white solid. IR (CHCl3) 2932, 1731, 1589, 1497 cm−1.
1H NMR (CDCl3) d 7.30–6.98 (10H, m), 4.35 (1H, br s), 3.43
(3H, s), 3.41 (1H, br d), 1.96–1.92 (1H, m), 1.78–1.59 (5H, m),
1.27–1.09 (5H, m). 13C NMR (CDCl3) d 174.1, 148.1, 129.0,
122.8, 121.0, 67.5, 51.3, 40.1, 29.8, 29.4, 26.2, 26.1. HRMS calcd
for C21H26N2O2 (M+) 338.2037, found 338.2015.
(3aR,6S,7aS)-1-[(2R)-2-Cyclopentyl-2-(2,2-diphenylhydrazino)-
acetyl]hexahydro-8,8-dimethyl-3H -3a,6-methano-2,1-benziso-
thiazole 2,2-dioxide [(R)-8c]. A colorless oil. [a]2D4 +39.5 (c
1.04, CHCl3). IR (CHCl3) 2961, 1692, 1589, 1493 cm−1. 1H
NMR (CDCl3) d 7.29–6.97 (10H, m), 4.60 (1H, br s), 4.28 (1H,
br s), 3.66 (1H, t, J = 6.3 Hz), 3.43, 3.37 (each 1H, d, J =
13.5 Hz), 2.30–2.22 (1H, m), 1.98–1.26 (15H, m), 1.08, 0.93
(each 3H, s). 13C NMR (CDCl3) d 174.0, 149.1, 128.9, 122.7,
121.4, 65.6, 65.1, 53.0, 48.3, 47.7, 44.4, 43.3, 38.3, 32.8, 29.2,
27.9, 26.4, 25.5, 25.4, 20.6, 19.9. HRMS calcd for C29H37N3O3S
(M+) 507.2553, found 507.2565.
2-(2,2-Diphenylhydrazino)-3,3-dimethylbutanoic acid methyl
ester (6e). A white solid. IR (CHCl3) 2955, 1729, 1589,
1
1498 cm−1. H NMR (CDCl3) d 7.32–6.98 (10H, m), 4.35 (1H,
br s), 3.36 (3H, s), 3.36 (1H, br d), 1.03 (9H, s). 13C NMR (CDCl3)
d 174.0, 148.5, 129.1, 122.9, 121.3, 71.4, 51.0, 34.2, 27.0. HRMS
calcd for C19H24N2O2 (M+) 312.1836, found 312.1840.
(3aR,6S,7aS)-Hexahydro-8,8-dimethyl-1-[(2E)-(diphenylhydra-
zono)acetyl]-3H-3a,6-methano-2,1-benzisothiazole 2,2-dioxide
(7). To a solution of (1R)-(+)-2,10-camphorsultam (1.0 g,
4.6 mmol) and 5 (1.8 g, 7.0 mmol) in CH2ClCH2Cl (60 mL)
was added Me3Al (1.0 M in hexane, 7.1 mL, 7.0 mmol) under a
nitrogen atmosphere at room temperature. After being heated
at reflux for 10 h, the reaction mixture was diluted with 36%
potassium sodium (+)-tartrate and then extracted with CH2Cl2.
The organic phase was washed with water, dried over MgSO4
and concentrated at a reduced pressure. Purification by flash
chromatography (CHCl3–hexane, 10 : 1) afforded 7 (1.23 g,
61%). Colorless crystals. mp 226–227 ◦C (AcOEt–hexane).
[a]2D1 +51 (c 1.00, CHCl3); IR (CHCl3) 3010, 2964, 1676, 1536,
((3aR,6S,7aS)-1-[(2S)-2-Cyclopentyl-2-(2,2-diphenylhydra-
zino)acetyl]hexahydro-8,8-dimethyl-3H-3a,6-methano-2,1-benz-
isothiazole 2,2-dioxide [(S)-8c]. A yellow solid. IR (CHCl3)
1
2959, 1691, 1589, 1493 cm−1. H NMR (CDCl3) d 7.27–6.96
(10H, m), 4.42 (1H, br s), 4.15 (1H, br d, J = 6.3 Hz), 3.82–3.77
(1H, m), 3.41, 3.34 (each 1H, d, J = 13.8 Hz), 2.35–2.28 (1H,
m), 1.94–1.25 (15H, m), 0.86, 0.80 (each 3H, s). HRMS calcd
for C29H37N3O3S (M+) 507.2554, found 507.2548.
O r g . B i o m o l . C h e m . , 2 0 0 5 , 3 , 1 1 2 4 – 1 1 2 8
1 1 2 7